Members of Dr. Jing Zhang’s lab then created a conditional transgenic model of AML using Mx1-Cre to induce homozygous loss of Trp53 in the hematopoietic system and concurrently induce expression of the oncogenic NrasG12D (164). Here, MX1 is linked to acute myeloid leukemia.